Tech Company Financing Transactions
Tolerogenics Funding Round
Tolerogenics closed a $50 thousand funding round on 12/31/2009. Investors included IllinoisVENTURES.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$50,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
20 N Wacker Dr 1201
Chicago, IL 60606
USA
Chicago, IL 60606
USA
Phone
Email Address
Not Recorded
Overview
The company is developing targeted approaches to the treatment of autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kathryn Hyer
Browse more venture capital transactions:
Prev: 12/31/2009: Core Solutions venture capital transaction
Next: 12/31/2009: Prenova venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs